glp 1 nutritional deficiency GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH What is GLP-1? Benefits, Uses

Davies, LixiLan-O Trial Investigators, Benefits of LixiLan, a titratable fixed-ratio combination of insulin Glargine plus Lixisenatide, versus insulin Glargine and Lixisenatide monocomponents in type 2 diabetes inadequately controlled on oral agents: The LixiLan-O randomized trial

J Clin Endocrinol Metab (2016) 101(5):195462.10.1210/jc.2015-3952 57 AdachiSTakiguchiSOkadaKYamamotoKYamasakiMMiyataHet alEffects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study

Wegovy received UK marketing authorisation in 2023, and NICE guidance (TA875) supports its use within the NHS for adults with a BMI of at least 35 kg/m (or 30 kg/m with weight-related comorbidities), when provided through specialist weight management services, and for a maximum duration of 2 years

Some studies show there may be a slight effect on GLP-1 levels from green tea, probiotics, and berberine

W.RosenstockJ.LahtelaJ